Logotype for Repligen Corporation

Repligen (RGEN) investor relations material

Repligen Stifel 2025 Healthcare Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Repligen Corporation
Stifel 2025 Healthcare Conference summary11 Nov, 2025

Financial performance and growth drivers

  • Achieved 18% organic growth in the quarter, with all key product areas up double digits and operating margins at 14.2% despite a 70 basis point decline.

  • Year-to-date non-COVID organic growth reached 16%, with analytics and protein franchises outperforming expectations.

  • Exposure to small biotech is now below 10%, with total exposure including CDMOs around 11-12%.

  • Commercial execution and key account management strategies have driven strong order intake and sales, especially in emerging biotech.

  • Margin expansion is targeted at 100-200 basis points per year, with significant investments in talent to support future scaling.

Product segment performance and innovation

  • Filtration guidance was adjusted from 11% to 10% growth due to supply delays, but underlying demand remains strong.

  • Chromatography (Chrome) saw a standout year after organizational changes, with new big pharma clients adopting pre-packed columns.

  • Protein segment benefited from a shift to custom and catalog resin development, with strong demand for new ligands and resins.

  • All four main franchises are expected to grow at similar CAGRs, supporting the goal to double company size in five years.

  • Hardware revenue grew 20%, with strong traction for downstream systems and PAT technologies.

Market trends and strategic outlook

  • Biopharma and CDMO segments have recovered, while small biotech showed a notable rebound in orders and sales.

  • New modalities, including cell therapy and antibody drug conjugates, are expected to drive growth over the next 5-10 years.

  • Cell therapy is a focus area, with strong ATF technology adoption and new PAT solutions following recent acquisitions.

  • Lipid nanoparticle (LNP) technology is seen as a broad opportunity, requiring innovation in filters, purification, and single-use components.

  • Onshoring in the US is expected to generate significant equipment demand starting in 2026, with hardware and downstream systems as likely beneficiaries.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Repligen earnings date

Logotype for Repligen Corporation
Jefferies London Healthcare Conference 202518 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Repligen earnings date

Logotype for Repligen Corporation
Jefferies London Healthcare Conference 202518 Nov, 2025

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process. The company's bioprocessing platforms includes technologies and systems used to develop, manufacture, store, test and distribute biotherapeutic products. It offers a portfolio that is engineered to meet the strict needs of biopharmaceutical manufacturers, and scalable to service the varied needs of manufacturing across the industry. The company sells its products through direct sales force and through applications engineering groups located in North America and Europe. Repligen Corporation is based in Waltham, Massachusetts.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage